ELIZABETH EAST: Open Payments
NPI 1598472912 · MOBERLY, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$420 in 22 payments from 12 companies in 2025. Trend: 2023 $232 · 2024 $218 · 2025 $420
Food & beverage: $420
| Company | Payments | Amount |
|---|---|---|
| Viatris Specialty LLC | 4 | $75 |
| AstraZeneca Pharmaceuticals LP | 3 | $60 |
| Radius Health, Inc. | 2 | $53 |
| VERTEX PHARMACEUTICALS INCORPORATED | 2 | $47 |
| Novo Nordisk Inc | 2 | $36 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $30 |
| ABBVIE INC. | 1 | $30 |
| Lundbeck LLC | 1 | $22 |
| Neurocrine BioSciences, Inc. | 1 | $21 |
| Teva Pharmaceuticals USA, Inc. | 1 | $17 |
Products named: YUPELRI, Tymlos, JOURNAVX, BREZTRI, CAPLYTA, QULIPTA, REXULTI, INGREZZA.
Industry payments across MO — which companies pay providers there.
